Ironwood Pharmaceuticals (IRWD -6.2%) takes a hit this morning, despite posting...

|About: Ironwood Pharmaceuticals, Inc. (IRWD)|By:, SA News Editor

Ironwood Pharmaceuticals (IRWD -6.2%) takes a hit this morning, despite posting better-than-expected Q4 results after the close yesterday. Cantor downgraded the shares to Sell on the report, citing a lack of revenue strength, reduced promotional spending, growing operating expenses and its current high valuation.